©2024 Stanford Medicine
68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer
Not Recruiting
Trial ID: NCT03113617
Purpose
This phase II trial studies how well gallium Ga 68-labeled gastrin-releasing peptide receptor
(GRPR) antagonist BAY86-7548 (68Ga-RM2) positron emission tomography (PET)/computed
tomography (CT) works in detecting regional nodal and distant metastases in patients with
intermediate or high-risk prostate cancer. 68Ga-RM2 PET/CT scan may be able to see smaller
tumors than the standard of care CT or magnetic resonance imaging scan.
Official Title
68Ga-RM2 PET/CT for Detection of Regional Nodal and Distant Metastases in Patients With Intermediate and High-Risk Prostate Cancer
Stanford Investigator(s)
Andrei Iagaru
Professor of Radiology (Nuclear Medicine)
Eligibility
Inclusion Criteria:
- Biopsy proven prostate adenocarcinoma
- Planned prostatectomy with lymph node dissection
- Intermediate to high-risk disease (as determined by elevated PSA [PSA > 10], T-stage
[T2b or greater], Gleason score [Gleason score > 6] or other risk factors)
- Able to provide written consent
- Karnofsky performance status of >= 50 (or Eastern Cooperative Oncology Group
[ECOG]/World Health Organization [WHO] equivalent)
- Diagnostic CT or magnetic resonance imaging (MRI) performed within 30 days prior to
the 68Ga-RM2 PET
Exclusion Criteria:
- Inability to lie still for the entire imaging time (approximately 30 minutes)
- Inability to complete the needed investigational and standard-of-care imaging
examinations due to other reasons (severe claustrophobia, radiation phobia, etc.)
- Any additional medical condition, serious intercurrent illness, or other extenuating
circumstance that, in the opinion of the Investigator, may significantly interfere
with study compliance
Intervention(s):
procedure: Computed Tomography
drug: Gallium Ga 68-labeled GRPR Antagonist BAY86-7548
other: Laboratory Biomarker Analysis
procedure: Positron Emission Tomography
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
David Marcellus
650-723-4547